Exemestane, an existing drug used to treat breast cancer, may prevent women from developing the disease.
American researchers have examined 4,560 healthy women from Europe and the United States on the effect of exemestane , with the aim of demonstrating breast cancer and finally fight † All women studied were in the same life stage:post menopause †
Fifty percent of the women studied received a placebo – also called a ‘fake medicine’, which looks exactly like the real medicine with active substance. From this group, 32 women . received eventually breast cancer. The other 50 percent did receive the drug exemstane administered. In this group, only 11 women breast cancer.
New breakthrough:HIV virus weakness discovered>
Side effects
As early as the 1990s, researchers showed that other drugs such as tamoxifen (an estrogen drug) and raloxifene (a medicine for breast cancer and other cancers) also had a good effect. Unfortunately, there was one major drawback to these two drugs:they had extremely nasty side effects , as heart attacks and blood clots.
Good news
Now the American researchers have shown that exemestane is much more suitable for taking preventively against breast cancer. Another advantage:exemestane has few side effects †
Now it remains to be investigated how long the women should take the drug against breast cancer after menopause. The researchers are guessing that women will have to take the drug preventively after the menopause for about five years for result.
More about breast cancer>
